Dengue Literature Review

Seet2007 - Post-Infectious Fatigue Syndrome in Dengue

6 min read

Seet2007 - Post-Infectious Fatigue Syndrome in Dengue

Full citation: Seet, R.C.S., Quek, A.M.L., & Lim, E.C.H. (2007). Post-infectious fatigue syndrome in dengue infection. Journal of Clinical Virology, 38(1), 1–6. https://doi.org/10.1016/j.jcv.2006.10.011

Raw file: [[raw/seet2007.pdf]]

Summary

This paper is the first prospective cohort study to systematically quantify post-dengue fatigue and identify its host-factor predictors. The authors recruited 127 hospitalized adults with serologically confirmed dengue from Singapore’s National University Hospital during the October–November 2005 dengue outbreak. A validated 11-item Fatigue Questionnaire (FQ) was administered by telephone 2 months after hospital discharge. Significant fatigue was present in 24.4% (31/127) of patients at that time point.

Multivariate logistic regression identified four independent predictors of post-infectious fatigue: older age, female sex, the presence of chills at acute presentation, and the absence of rashes. No haematologic or biochemical laboratory parameter predicted fatigue, and — critically — dengue severity (DF vs. DHF) was not associated with fatigue outcome (p = 0.855). The authors interpret this severity-independence as evidence that host factors, rather than viral pathogenic load, drive the post-acute syndrome.

The paper frames post-dengue fatigue within the broader literature on post-infectious fatigue syndromes (EBV: 38–40%, Q fever: 31%), positioning dengue at 24.4% as a less severe but real member of this class. It proposes that immune alterations triggered by dengue — including CD4/CD8 ratio inversion and C3a/C5a-mediated endothelial damage — may interact with the hypothalamic–pituitary–adrenal axis to produce the fatigue phenotype, though the mechanism is acknowledged as speculative.

Study Design

  • Type: Prospective cohort with 2-month telephone follow-up
  • Sample size: 127 (from 163 screened; 36 excluded — 25 left Singapore, 6 declined, 5 insufficient English)
  • Setting: National University Hospital, Singapore; October–November 2005 dengue outbreak
  • Population: Hospitalized adults ≥16 years; serologically confirmed dengue; 19.7% DHF, 80.3% DF; mean age 36 years (range 16–70)

Key Findings

  • 24.4% (31/127) of hospitalized dengue patients had significant post-infectious fatigue at 2 months by validated Fatigue Questionnaire
  • Dengue severity did not predict fatigue: DHF vs. DF showed no significant association (p = 0.855, OR 0.851, 95% CI 0.151–4.783)
  • No laboratory parameter (WBC, haemoglobin, platelet count, liver enzymes, coagulation times) was significantly associated with fatigue
  • Multivariate predictors of fatigue:
    • Older age (OR 1.118; 95% CI 1.033–1.209; p = 0.006)
    • Female sex (OR 9.687; 95% CI 1.546–60.684; p = 0.015)
    • Presence of chills (OR 6.904; 95% CI 1.157–41.202; p = 0.034)
    • Absence of rashes (OR 38.462; 95% CI 1.292–58.824; p = 0.026)
  • Serotype data (subset of 27 patients with RT-PCR): DEN-1 in 20 patients (74%), DEN-3 in 6 (22%), DEN-4 in 1 (4%) — DEN-1 was the dominant circulating serotype in Singapore during this outbreak
  • Fatigue rate lower than post-EBV (38–40%) and post-Q-fever (31%), but in the same phenomenological class
  • Ethnicity distribution: Chinese 75.6%, Malay 17.3%, Indian 4.7% — consistent with Singapore’s demographic composition

Methods Used

  • IgM-IgG Serology ELISA — double-sandwich capture ELISA (Innis et al. 1989 protocol); single serum: 40 IgM units as threshold for acute dengue; repeat serology at 2-week outpatient follow-up in initially IgM-negative patients
  • RT-PCR — reverse transcriptase-nested PCR (Lanciotti et al. 1992 protocol) for DENV serotyping in a subset
  • WHO 1997 DHF/DSS clinical classification criteria (plasma leakage + thrombocytopenia; platelet <100,000/µL)
  • Fatigue Questionnaire (FQ; Dittner et al. 2004) — 11-item validated instrument; 7 physical + 4 mental fatigue items; score ≥4 on dichotomized scale = significant fatigue case
  • Logistic regression (SPSS 13.0) for multivariate analysis

Entities Mentioned

  • DENV-1 (dominant serotype Singapore 2005 outbreak)
  • DENV-3 (minor serotype in same outbreak)
  • DENV-4 (single case in serotyped subset)

Concepts Addressed

Relevance & Notes

This paper is the second post-dengue cohort study in the wiki (after Garcia2009 - Long-term Clinical Symptoms Post-Dengue) and provides a methodologically independent confirmation that dengue causes clinically meaningful post-acute sequelae. The two papers share one key structural finding despite differing in country (Singapore vs. Cuba), serotype (DEN-1 dominant vs. DENV-4), follow-up duration (2 months vs. 2 years), and outcome measured (fatigue vs. multi-system autoimmune markers + musculoskeletal symptoms): acute dengue severity does not predict who will suffer post-acute consequences. In Garcia2009, DF vs. DHF did not predict sequelae (p = 0.086); in Seet2007, DF vs. DHF did not predict fatigue (p = 0.855). This cross-cohort consistency strengthens the inference that post-dengue syndrome is host-driven, not virus-severity-driven.

The female sex OR of 9.687 in Seet2007 is notably large. This parallels Garcia2009’s female predominance (65.7% of women vs. 36.7% of men with sequelae at 2 years, p = 0.008), and aligns with the well-established female excess in autoimmune diseases and ANA positivity (see Antinuclear Antibodies, Autoimmunity in Dengue). That the same sex disparity appears in both a fatigue outcome (2 months post-dengue, Singapore) and an autoimmune marker outcome (2 years post-dengue, Cuba) suggests sex is a general modifier of post-dengue immune sequelae — potentially reflecting shared immunological mechanisms (hormonal regulation of FcγR expression, Th1/Th2 balance, etc.).

Important limitations:

  • Only hospitalized patients recruited — excludes the majority of dengue infections (ambulatory DF, asymptomatic). Post-infectious fatigue rate in the community may differ substantially.
  • Follow-up only 2 months — does not address whether fatigue resolves or persists beyond this window; cannot determine if the 2-month fatigue cohort overlaps with Garcia2009’s 2-year sequelae cohort phenomenologically.
  • Psychological pre-morbid state not assessed — individual variation in fatigue perception and reporting not controlled.
  • English-language restriction in a multilingual setting may introduce selection bias.
  • 27/127 patients had virological serotyping; serotype distribution is from a minority subset and may not represent the full outbreak.

Questions Raised

  • Does post-dengue fatigue in this cohort resolve by 6 months or 1 year? The 2-month window is too short to determine whether this is transient or prolonged.
  • Is the OR 9.687 for female sex for fatigue driven by the same mechanism as the female predominance of post-dengue autoimmune markers in Garcia2009 — or are they phenomenologically related but mechanistically distinct?
  • Why do chills predict fatigue but rashes protect against it? Both are common dengue symptoms; their divergent roles suggest different pathophysiological axes are active in patients presenting with one vs. the other.
  • Do DEN-1 vs. DEN-3 patients in the serotyped subset differ in their fatigue rates — and if so, does serotype modulate post-infectious sequelae independently of severity?

Graph View

Backlinks